What should be done when thyroid function tests do not make sense?

Clinical Endocrinology

Volumn 74, Issue 6, 2011, Pages 673-678

  Gurnell, Mark ^a,b   Halsall, David J ^b   Chatterjee, V Krishna ^a,b  

^a INSTITUTE OF METABOLIC SCIENCE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMIODARONE; ANTIBODY; CHOLESTEROL; CREATINE KINASE; FATTY ACID; GLUCOCORTICOID; HETEROPHILE ANTIBODY; HUMAN ANTIANIMAL ANTIBODY; IODINATED CONTRAST MEDIUM; LIOTHYRONINE; LIPOPROTEIN LIPASE; MONOCARBOXYLATE TRANSPORTER 8; ORAL CONTRACEPTIVE AGENT; PROPRANOLOL; PROPYLTHIOURACIL; PROTIRELIN; RHEUMATOID FACTOR; SEX HORMONE BINDING GLOBULIN; TAMOXIFEN; THYROID HORMONE; THYROTROPIN; THYROTROPIN RECEPTOR; THYROXINE; THYROXINE BINDING GLOBULIN; UNCLASSIFIED DRUG;

ALBUMIN BLOOD LEVEL; ALPHA CHAIN; ANTIBODY BLOOD LEVEL; ANTIGEN BINDING; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CREATINE KINASE BLOOD LEVEL; DEIODINASE DEFICIENCY; ENZYME DEFICIENCY; EQUILIBRIUM DIALYSIS; ESTROGEN THERAPY; EUTHYROIDISM; FAMILY HISTORY; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GENETIC SCREENING; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; HYPERTHYROXINEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHYROIDISM; LABORATORY TEST; LIOTHYRONINE BLOOD LEVEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; THYROID ADENOMA; THYROID FUNCTION TEST; THYROID HORMONE BLOOD LEVEL; THYROID HORMONE RESISTANCE; THYROTOXICOSIS; THYROTROPIN BLOOD LEVEL; THYROTROPIN SECRETING ADENOMA; THYROXINE BLOOD LEVEL;

ALGORITHMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERTHYROXINEMIA; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; THYROID FUNCTION TESTS; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 79955814333     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04023.x     Document Type: Article

References (34)

1. Beckett, G.J., &, Toft, A.D., (2003) First-line thyroid function tests-TSH alone is not enough. Clinical Endocrinology, 58, 20-21. (Pubitemid 36098843)
2. Association for Clinical Biochemistry/British Thyroid Association/British Thyroid Foundation joint guidelines. Available at:.
3. National Academy of Clinical Biochemistry guidelines. Available at:.
4. Thyroid Disease Manager. Available at
5. Andersen, S., Pedersen, K.M., Bruun, N.H., et al. (2002) Narrow individual variations in serum T4 and T3 in normal subjects: a clue to the understanding of subclinical thyroid disease. Journal of Clinical Endocrinology and Metabolism, 87, 1068-1072. (Pubitemid 36121067)
6. Gurnell, M., Visser, T., Beck-Peccoz, P., et al. (2010) Resistance to thyroid hormone. In:, J.L. Jameson, L.J. De Groot, eds Endocrinology, 6th edn. Saunders Elsevier, Philadelphia, PA, 1745-1759.
7. Bartalena, L., &, Robbins, J., (1992) Variations in thyroid-hormone transport proteins and their clinical implications. Thyroid, 2, 237-245.
8. Cartwright, D., O'Shea, P., Rajanayagam, O., et al. (2009) Familial dysalbuminemic hyperthyroxinaemia: a persistent diagnostic challenge. Clinical Chemistry, 55, 1044-1046.
9. Després, N., &, Grant, A.M., (1998) Antibody interference in thyroid assays: a potential for clinical misinformation. Clinical Chemistry, 44, 440-454. (Pubitemid 28141337)
10. Verhoye, E., Van den Bruel, A., Delanghe, J.R., et al. (2009) Spuriously high thyrotropin values due to anti-thyrotropin antibodies in adult patients. Clinical Chemistry and Laboratory Medicine, 47, 604-606.
11. Kaplan, I.V., &, Levinson, S.S., (1999) When is a heterophile antibody not a heterophile antibody? When it is an antibody against a specific immunogen. Clinical Chemistry, 45, 616-618. (Pubitemid 29220321)
12. Ross, H.A., Menheere, P.P., Endocrinology Section of SKML (Dutch Foundation for Quality Assessment in Clinical Laboratories), Thomas, C.M., et al. (2008) Interference from heterophilic antibodies in seven current TSH assays. Annals of Clinical Biochemistry, 45, 616.
13. Norden, A.G., Jackson, R.A., Norden, L.E., et al. (1997) Misleading results from immunoassays of serum free thyroxine in the presence of rheumatoid factor. Clinical Chemistry, 43, 957-962. (Pubitemid 27246985)
14. Halsall, D.J., Fahie-Wilson, M.N., Hall, S.K., et al. (2006) Macro thyrotropin-IgG complex causes factitious increases in thyroid-stimulating hormone screening tests in a neonate and mother. Clinical Chemistry, 52, 1968-1969. (Pubitemid 44470708)
15. Sakai, H., Fukuda, G., Suzuki, N., et al. (2009) Falsely elevated thyroid-stimulating hormone (TSH) level due to macro-TSH. Endocrine Journal, 56, 435-440.
16. Stevenson, H.P., Archbold, G.P., Johnston, P., et al. (1998) Misleading serum free thyroxine results during low molecular weight heparin treatment. Clinical Chemistry, 44, 1002-1007. (Pubitemid 28213140)
17. Wood, D.F., Zalin, A.M., Ratcliffe, W.A., et al. (1987) Elevation of free thyroxine measurements in patients without thyrotoxicosis. Quarterly Journal of Medicine, 65, 863-870. (Pubitemid 18012578)
18. Zouwail, S.A., O'Toole, A.M., Clark, P.M., et al. (2008) Influence of thyroid hormone autoantibodies on 7 thyroid hormone assays. Clinical Chemistry, 54, 927-928. (Pubitemid 351671614)
19. Holm, S.S., Hansen, S.H., Faber, J., et al. (2004) Reference methods for the measurement of free thyroid hormones in blood. Evaluation of potential reference methods for free thyroxine. Clinical Biochemistry, 37, 85-93. (Pubitemid 38077157)
20. International Federation of Clinical Chemistry and Laboratory Medicine IFCC, IFCC Scientific Division Working Group for Standardization of Thyroid Function Tests WG-STFT, Thienpont, L.M., Beastall, G., Christofides, N.D., et al. (2007) Proposal of a candidate international conventional reference measurement procedure for free thyroxine in serum. Clinical Chemistry and Laboratory Medicine, 45, 934-936. (Pubitemid 47041898)
21. Stockigt, J.R., &, Lim, C., (2009) Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine. Best Practice & Research Clinical Endocrinology & Metabolism, 23, 753-767.
22. Morris, J.C., (2009) How do you approach the problem of TSH elevation in a patient on high-dose thyroid hormone replacement? Clinical Endocrinology, 70, 671-673.
23. Cohen-Lehman, J., Dahl, P., Danzi, S., et al. (2010) Effects of amiodarone therapy on thyroid function. Nature Reviews Endocrinology, 6, 34-41.
24. Arem, R., &, Cusi, K., (1997) Thyroid function testing in psychiatric illness. Trends in Endocrinology and Metabolism, 8, 282-287.
25. Socin, H.V., Chanson, P., Delemer, B., et al. (2003) The changing spectrum of TSH-secreting pituitary adenomas: diagnosis and management in 43 patients. European Journal of Endocrinology, 148, 433-442. (Pubitemid 36527414)
26. Beck-Peccoz, P., Persani, L., Mannavola, D., et al. (2009) TSH-secreting adenomas. Best Practice & Research Clinical Endocrinology & Metabolism, 23, 597-606.
27. Gurnell, M., Rajanayagam, O., Barbar, I., et al. (1998) Reversible pituitary enlargement in the syndrome of resistance to thyroid hormone. Thyroid, 8, 679-682. (Pubitemid 28405155)
28. Sarne, D.H., Refetoff, S., Rosenfield, R.L., et al. (1988) Sex hormone-binding globulin in the diagnosis of peripheral tissue resistance to thyroid hormone: the value of changes after short term triiodothyronine administration. Journal of Clinical Endocrinology & Metabolism, 66, 740-746.
29. Mannavola, D., Persani, L., Vannucchi, G., et al. (2005) Different response to chronic somatostatin analogues in patients with central hyperthyroidism. Clinical Endocrinology, 62, 176-181. (Pubitemid 40203912)
30. Friesema, E.C., Grueters, A., Biebermann, H., et al. (2004) Associations between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation. Lancet, 364, 1435-1437. (Pubitemid 39370719)
31. Dumitrescu, A.M., Liao, X.H., Best, T.B., et al. (2004) A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene. American Journal of Human Genetics, 74, 168-175. (Pubitemid 38085248)
32. Dumitrescu, A.M., Liao, X.H., Abdullah, M.S., et al. (2005) Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nature Genetics, 37, 1247-1252. (Pubitemid 41568708)
33. Schoenmakers, E., Agostini, M., Mitchell, C., et al. (2010) Mutations in the selenocysteine insertion sequence-binding protein 2 gene lead to a multisystem selenoprotein deficiency disorder in humans. Journal of Clinical Investigation, 120, 4220-4235.
34. Azevedo, M.F., Barra, G.B., Naves, L.A., et al. (2010) Selenoprotein-related disease in a young girl caused by nonsense mutations in the SBP2 gene. Journal of Clinical Endocrinology & Metabolism, 95, 4066-4071.